It was believed to induce insulin resistance in adipose tissues by altering the normal insulin signaling pathway, stimulating adipocyte lipolysis, inhibiting serine phosphorylation of IRS-1 activity thereby decreasing glucose transporter ‘GLUT4’ synthesis and membrane translocation [43–45]. The gene discussed is SLC2A4; the disease is Insulin resistance.